These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25051397)

  • 1. Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: recruiting histone deacetylase and inhibiting activator protein 1 transcription factors.
    Shi Q; Li J; Feng Z; Zhao L; Luo L; You Z; Li D; Xia J; Zuo G; Chen D
    Mol Med Rep; 2014 Oct; 10(4):1779-85. PubMed ID: 25051397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Effect of Rh2, a Histone Deacetylase Inhibitor, in HepG2 Cells and HepG2 Cell-Derived Xenograft Tumors Occurs via the Inhibition of HDACs and Activation of the MAPK Signaling Pathway.
    Qiang SQ; Qin GC; Jing L; Qiang FZ; Mei QH; Long CD
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2529-2539. PubMed ID: 34452568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
    Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
    Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin.
    Shi Q; Shi X; Zuo G; Xiong W; Li H; Guo P; Wang F; Chen Y; Li J; Chen DL
    Oncol Rep; 2016 Oct; 36(4):2059-70. PubMed ID: 27573179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells.
    Yoon JH; Choi YJ; Lee SG
    Eur J Pharmacol; 2012 Mar; 679(1-3):24-33. PubMed ID: 22314224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
    Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL
    Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells.
    Bae EA; Kim EJ; Park JS; Kim HS; Ryu JH; Kim DH
    Planta Med; 2006 Jun; 72(7):627-33. PubMed ID: 16673329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription.
    Li Q; Li B; Dong C; Wang Y; Li Q
    Eur J Pharmacol; 2017 Nov; 815():173-180. PubMed ID: 28928088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JNK pathway and relative transcriptional factor were involved in ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
    Liu X; Sun Y; Yue L; Li S; Qi X; Zhao H; Yang Y; Zhang C; Yu H
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
    Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
    Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
    Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY
    World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism.
    Liu GW; Liu YH; Jiang GS; Ren WD
    Hum Cell; 2018 Jul; 31(3):189-198. PubMed ID: 29582366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2.
    Wang YS; Chen C; Zhang SY; Li Y; Jin YH
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ginsenoside Rh₂-induced inhibition of histone deacetylase 6 promotes K562 cells autophagy and apoptosis in vivo].
    Liu ZH; Chen DL; Jiang R; Chen Y; Xiong W; Wang F; Shi XP; Li HX; Li J
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):700-704. PubMed ID: 28871696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray analysis of altered long non-coding RNA expression profile in liver cancer cells treated by ginsenoside Rh2.
    Chen WW; Huang YF; Hu ZB; Liu YM; Xiao HX; Liu DB; Zhuang YZ
    J Asian Nat Prod Res; 2019 Aug; 21(8):742-753. PubMed ID: 30394104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Octyl Ester of Ginsenoside Rh2 Induces Lysosomal Membrane Permeabilization via Bax Translocation.
    Chen F; Zhang B; Sun Y; Xiong ZX; Peng H; Deng ZY; Hu JN
    Nutrients; 2016 Apr; 8(5):. PubMed ID: 27120618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esterification of Ginsenoside Rh2 Enhanced Its Cellular Uptake and Antitumor Activity in Human HepG2 Cells.
    Chen F; Deng ZY; Zhang B; Xiong ZX; Zheng SL; Tan CL; Hu JN
    J Agric Food Chem; 2016 Jan; 64(1):253-61. PubMed ID: 26672619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.
    He L; Lee J; Jang JH; Lee SH; Nan MH; Oh BC; Lee SG; Kim HH; Soung NK; Ahn JS; Kim BY
    Bone; 2012 Jun; 50(6):1207-13. PubMed ID: 22484180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Chen W; Qiu Y
    Cell Biochem Biophys; 2015 Jun; 72(2):325-31. PubMed ID: 25561284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.